CRYAB Gene Cardiomyopathy Dilated Type 1 Genetic Test
Components:
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type:
Cardiovascular Pneumology Disorders
Doctor:
Cardiologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for CRYAB Gene Cardiomyopathy, dilated type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRYAB Gene Cardiomyopathy, dilated type 1 NGS Genetic DNA Test gene CRYAB
Test Details:
The CRYAB gene is responsible for providing instructions for making a protein called alpha-B crystallin, which is found in the heart, skeletal muscles, and other tissues. Mutations in the CRYAB gene can lead to a condition called dilated cardiomyopathy type 1 (CMD1). Dilated cardiomyopathy is a disorder characterized by the enlargement of the heart chambers and weakened heart muscle, leading to decreased heart function. CMD1 is specifically associated with mutations in the CRYAB gene.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of dilated cardiomyopathy, NGS genetic testing can be used to identify mutations in the CRYAB gene and other genes associated with the condition. NGS genetic testing for dilated cardiomyopathy can help in the diagnosis, prognosis, and treatment of individuals with suspected or confirmed CMD1. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.
It is important to note that genetic testing for dilated cardiomyopathy should be performed and interpreted by a qualified healthcare professional or genetic counselor, as the results may have significant implications for the individual and their family.
| Test Name | CRYAB Gene Cardiomyopathy dilated type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CRYAB Gene Cardiomyopathy, dilated type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRYAB Gene Cardiomyopathy, dilated type 1 NGS Genetic DNA Test gene CRYAB |
| Test Details |
The CRYAB gene is responsible for providing instructions for making a protein called alpha-B crystallin, which is found in the heart, skeletal muscles, and other tissues. Mutations in the CRYAB gene can lead to a condition called dilated cardiomyopathy type 1 (CMD1). Dilated cardiomyopathy is a disorder characterized by the enlargement of the heart chambers and weakened heart muscle, leading to decreased heart function. CMD1 is specifically associated with mutations in the CRYAB gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of dilated cardiomyopathy, NGS genetic testing can be used to identify mutations in the CRYAB gene and other genes associated with the condition. NGS genetic testing for dilated cardiomyopathy can help in the diagnosis, prognosis, and treatment of individuals with suspected or confirmed CMD1. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling. It is important to note that genetic testing for dilated cardiomyopathy should be performed and interpreted by a qualified healthcare professional or genetic counselor, as the results may have significant implications for the individual and their family. |
